Medical
technology company IsoRay, an innovator in seed brachytherapy and medical
radioisotope applications, announced that two new medical centers are using its
sutured seeds in mesh for the treatment of colon and lung cancers.
IsoRay
is encouraged by the number of new facilities that are noting successes
achieved by other major cancer centers where the company’s Cesium-131 sutured
seeds are being made available to patients.
“We
are excited to have the University of California and John Muir Medical Center
as our newest thought leaders utilizing Cesium-131 products for newly diagnosed
and recurrent cancers where other treatments have previously failed,” said
IsoRay CEO Dwight Babcock. “Currently, all of our studies in multiple medical
centers are performing well with positive results in treating brain cancers,
meningioma tumors, pelvic wall, lung cancer, colon cancer, gynecologic cancer
and prostate cancer with our Cesium-131 product line. We are making a
difference in thousands of lives by providing new ideas and solutions in the
battle against cancer and we believe Cesium-131 is the isotope of the future.”
The
company’s Cesium-131 sutured seeds, stranded mesh, and the GliaSite radiation
therapy system each enable doctors to directly place a specific radiation
dosage in areas where cancer is most likely to remain after brain tumor removal
has been completed. Being able to precisely place a specified dosage of
radiation means less likelihood of damage occurring to healthy brain and lung
tissue and critical structures, as compared with other alternative treatments.
Cancer-fighting products provided by IsoRay reduce a tumor’s ability to recur,
resulting in important longevity and quality of life benefits.
Cesium-131,
the first new isotope to be available in seed form for brachytherapy in around
two decades, is exclusively manufactured by IsoRay. Cesium-131 enables precise
treatment of various cancers due to its unparalleled blend of high energy and
its 9.7-day half-life.
For
more information, visit www.isoray.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
